PARSIDOL Drug Patent Profile
✉ Email this page to a colleague
When do Parsidol patents expire, and when can generic versions of Parsidol launch?
Parsidol is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in PARSIDOL is ethopropazine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the ethopropazine hydrochloride profile page.
Summary for PARSIDOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 27 |
Patent Applications: | 4,795 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PARSIDOL at DailyMed |
US Patents and Regulatory Information for PARSIDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | PARSIDOL | ethopropazine hydrochloride | TABLET;ORAL | 009078-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | PARSIDOL | ethopropazine hydrochloride | TABLET;ORAL | 009078-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | PARSIDOL | ethopropazine hydrochloride | TABLET;ORAL | 009078-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |